<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>同写意 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-17T20:30:23+08:00</updated>
  <subtitle>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>写意报告︱梁子才：小核酸药物将成为现代制药“第三次浪潮”</title>
    <updated>2020-12-17T18:32:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/VjMsAzk0nBtv1Cs04XfJFw</id>
    <link href="https://mp.weixin.qq.com/s/VjMsAzk0nBtv1Cs04XfJFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020医保目录谈判，看到几个可以聊聊的机会</title>
    <updated>2020-12-17T18:32:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/yk4o_5GTcWmTE6baViKcuA</id>
    <link href="https://mp.weixin.qq.com/s/yk4o_5GTcWmTE6baViKcuA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首个KRAS靶点药物安进AMG 510递交上市申请</title>
    <updated>2020-12-17T18:32:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/3mMweUfi64qR7N11YcjNPQ</id>
    <link href="https://mp.weixin.qq.com/s/3mMweUfi64qR7N11YcjNPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博腾股份通过WHO GMP认证，地瑞拉韦原料药授权事项取得里程碑进展</title>
    <updated>2020-12-17T18:32:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/zUN83N5JqynuQEMn04qLdQ</id>
    <link href="https://mp.weixin.qq.com/s/zUN83N5JqynuQEMn04qLdQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同写意 | 药明直播间：应对挑战——ADC药物研发及生产的关键策略考量</title>
    <updated>2020-12-17T18:32:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/bs3npl6fOEwHw8xGQcZ1Zg</id>
    <link href="https://mp.weixin.qq.com/s/bs3npl6fOEwHw8xGQcZ1Zg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新一代补体治疗药物的临床应用前景</title>
    <updated>2020-12-16T20:30:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/_UbZELt9Qgd2HsKsI3eH9Q</id>
    <link href="https://mp.weixin.qq.com/s/_UbZELt9Qgd2HsKsI3eH9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会员机构丨易迪希：​临床研究领域云解决方案领导者</title>
    <updated>2020-12-16T20:30:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/GbdmXT8XnbMXLaUtN2eCow</id>
    <link href="https://mp.weixin.qq.com/s/GbdmXT8XnbMXLaUtN2eCow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大盘点：2020全球生物医药交易TOP10</title>
    <updated>2020-12-16T20:30:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/fTalSYmbN8YSxgymQlHAVw</id>
    <link href="https://mp.weixin.qq.com/s/fTalSYmbN8YSxgymQlHAVw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同写意论坛112期丨问道2021，药品创新投资何处去？</title>
    <updated>2020-12-15T21:45:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/1_SGmwi1J-LPSeCnH9DorQ</id>
    <link href="https://mp.weixin.qq.com/s/1_SGmwi1J-LPSeCnH9DorQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>免费参会！15位专家齐聚“生物医药研发及质量控制论坛”</title>
    <updated>2020-12-15T21:45:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/4aVh-6E3xXfYdQeDGENI7A</id>
    <link href="https://mp.weixin.qq.com/s/4aVh-6E3xXfYdQeDGENI7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨众生睿创完成2.8亿元B轮融资</title>
    <updated>2020-12-15T21:45:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/I9Twht9V0xP40HIBH7acZw</id>
    <link href="https://mp.weixin.qq.com/s/I9Twht9V0xP40HIBH7acZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨鸿运华宁郑州生产基地启动，为单抗药物上市及国际化做准备</title>
    <updated>2020-12-15T21:45:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/Ox3FzjRFmbxwwoIkJriAZA</id>
    <link href="https://mp.weixin.qq.com/s/Ox3FzjRFmbxwwoIkJriAZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同写意 | 药明直播间：大动物疾病模型——赋能新药研发并提高临床转化成功率</title>
    <updated>2020-12-15T21:45:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/Hfi9U9t30Svibva5TXoNhg</id>
    <link href="https://mp.weixin.qq.com/s/Hfi9U9t30Svibva5TXoNhg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>被AZ以390亿美元并购的Alexion是干什么的？</title>
    <updated>2020-12-14T18:56:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/Votur-WLVm7ZVI-G4GonsA</id>
    <link href="https://mp.weixin.qq.com/s/Votur-WLVm7ZVI-G4GonsA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>TKI药物研发及伴随诊断审批思路变迁丨泛生子BIONNOVA干货分享</title>
    <updated>2020-12-14T18:56:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/3-RZhDGkRMrc9imZtsYA1A</id>
    <link href="https://mp.weixin.qq.com/s/3-RZhDGkRMrc9imZtsYA1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>埃格林医药正式启动中/重度新冠肺炎口服治疗药的临床一期试验</title>
    <updated>2020-12-14T18:56:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/UiuZVhQi2j9JieaixG_eRQ</id>
    <link href="https://mp.weixin.qq.com/s/UiuZVhQi2j9JieaixG_eRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同写意 | 药明直播间：大动物疾病模型——赋能新药研发并提高临床转化成功率</title>
    <updated>2020-12-14T18:56:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/RUZ1k03k28EN_OEHCFf7IA</id>
    <link href="https://mp.weixin.qq.com/s/RUZ1k03k28EN_OEHCFf7IA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>程增江主持对话MAH制度下药品MAH转化平台实操</title>
    <updated>2020-12-13T19:11:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/bO-UVucOhvjA9fkwdWjkPg</id>
    <link href="https://mp.weixin.qq.com/s/bO-UVucOhvjA9fkwdWjkPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关注杜丨从诺华的高胆固醇血症新药看商业竞争</title>
    <updated>2020-12-13T19:11:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/VTmwT3m3TuRM0s8S53E3LA</id>
    <link href="https://mp.weixin.qq.com/s/VTmwT3m3TuRM0s8S53E3LA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-(L)1的千亿市场是不是伪命题？</title>
    <updated>2020-12-13T19:11:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/NTRn75SFfBZ34flkJnleGA</id>
    <link href="https://mp.weixin.qq.com/s/NTRn75SFfBZ34flkJnleGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>